Mycophenolate Mofetil Powder, For Suspension
Product Images NDC 67877-230

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 67877-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mycophenolate-carton (Mycophenolate Carton)

Mycophenolate-carton (Mycophenolate Carton)
This is a prescription of Mycophenolate Mofetil For Oral Suspension USP. The bottle contains 175mL of solution after being mixed and it needs to be stored at a temperature of 25°C (77°F); excursions permitted to 15°-30°C (59*-86°F) and not to be frozen. Discard any unused portion 60 days after constitution. The instructions to the pharmacist include the measurement of 91 mL of water in a graduated cylinder and add it to the closed bottle while shaking it well. The bottle is delivered with two oral dispensers and patient instructions. At the bottom of the prescription, we find the name of the pharmaceutical laboratories involved in manufacturing and distributing this medication.*
FDA Label Image

Mycophenolate-container (Mycophenolate Container)

Mycophenolate-container (Mycophenolate Container)
This is a description for a medication called Mycophenolate Mofetil, which is available in the form of oral suspension. Each L (unit of package) contains 200mg of the medication after preparation. The pack contains 350 grams of mycophenolate mofetil, which is dilutable to a volume of 160-165 L. There is a pharmaceutical warning that the medication contains 0.56 mg of phenylalanine after preparation. The provided instructions guide the pharmacist to shake the bottle well before use and also provide the correct procedure for reconstitution. The medication should be stored at temperatures between 15-30°C and must not be frozen. Any unused portion should be discarded 60 days after the reconstitution date. The medication is manufactured by Alkem Laboratories in India and is distributed by Ascend Laboratories in the USA.*
FDA Label Image

Mycophenolate-fig1.jpg (Mycophenolate Fig1)

Mycophenolate-fig1.jpg (Mycophenolate Fig1)
This looks like a description of a product called "Oral Dispenser" that comes with a child-resistant bottle and a plunger. Unfortunately, there is not enough context to determine the purpose of this product, but it may be used for dispensing medication or other liquids.*
FDA Label Image

Mycophenolate-fig2.jpg (Mycophenolate Fig2)

FDA Label Image

Mycophenolate-structure-.jpg (Mycophenolate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.